IN THIS SECTION
Overview
Management
SAB


About : Our Management

Divyen H. Patel Ph.D. Founder/CEO
Dr. Patel has focused his entire scientific career in trying to find novel and innovative ways to improve the outcome in cancer patients. He completed his Ph.D. at the University of Leeds in England, publishing 14 publications as a graduate student, focusing on establishing definitive methods for diagnosis of myeloid leukemia. He joined the University of Tennessee in 1992 to study signal transduction to get a better understanding of the causative agents of various disease states. Dr. Patel started his work on differential gene expression in 1994 when he joined St. Jude Children's Research Hospital in Memphis TN. At the time he utilized the rudimentary tools available to clone and characterize nucleoside transporter cDNAs. He subsequently initiated and ran an Affymetrix GeneChip microarray facility at St. Jude's. His extensive experience and background in the field of gene expression research allowed him to help many investigators to further their research projects.



Dr. R. Dale Childress M.D., CMO
Dr. Childress has maintained a life-long interest in research, with his first co-authored publication in the American Journal of Physiology at age 18.  Dr. Childress received his Masters of Science in Cellular and Molecular Biology in 1997 and his M.D. degree in 1999, both from Louisiana State University in Shreveport.  He obtained his Internal Medicine residency training and Endocrinology Fellowship training at the University of Tennessee Health Science Center in Memphis.  Dr. Childress currently maintains a private endocrinology practice in the community as well as working at the Memphis Veterans Affairs hospital where he serves as an associate professor in the division of endocrinology.  He serves on consultant boards, as well as a speaker for several pharmaceutical companies. He also serves as a peer reviewer for several scientific/clinical journals.  In his current capacity as CMO, Dr. Childress directly facilitates all clinical studies undertaken by Genome Explorations. He provides an essential interface between scientific advancements and clinical research.

Robert J. Rooney Ph.D., Scientific Director
Prior to his move to Genome Explorations in July 2004, Dr. Rooney was a faculty member in the Department of Molecular Genetics & Microbiology at Duke University Medical Center from 1998 to 2004 and in the Department of Biochemistry at St. Jude Children's Research Hospital from 1992 to 1998. He received his Ph.D. from Columbia University and post-doctoral training at The Rockefeller University and Duke University. Dr. Rooney has been the principal investigator on multiple grants from the NIH and the American Cancer Society and his research interests have encompassed mechanisms regulating mammalian and viral gene transcription, cell cycle control, signal transduction, apoptosis, and oncogenesis.

Contact Us
Ordering
Careers